Article info

Extended report
Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone

Authors

  1. Correspondence to Professor Xu Cao, Department of Orthopaedic Surgery, Institute for Cell Engineering, Johns Hopkins University, Baltimore, MD 21205, USA; xcao11{at}jhmi.edu and Bin Yu; yubinol{at}163.com
View Full Text

Citation

Cui Z, Crane J, Xie H, et al
Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone

Publication history

  • Received May 14, 2015
  • Revised September 1, 2015
  • Accepted September 20, 2015
  • First published October 15, 2015.
Online issue publication 
November 02, 2019

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.